Blindness News and Research

RSS

Metformin should be in the first line of defense against type 2 diabetes

A new review of studies confirms that the drug metformin should be in the first line of defense against type 2 diabetes. Using metformin alone can improve control of blood glucose, while also reducing risk factors for heart disease such as excess body weight, cholesterol levels and hypertension, the review found.

20 Jul 2005

America's Children: Key National Indicators of Well-Being 2005

The adolescent birth rate has reached another record low, the death rate for children between ages 1 and 4 is the lowest ever, young children are more likely to receive their recommended immunizations, and fourth graders are scoring better in math, according to a yearly compendium of statistics from federal agencies concerned with children.

20 Jul 2005

Nitric oxide good for some prem babies but not for others

According to two new studies, although nitric oxide can halve the risk of developmental problems in premature babies with undeveloped lungs, the gas could be harmful to newborns who are too small and too ill.

7 Jul 2005

G8 must focus on healthcare to save millions of lives

Millions of people are dying in the developing world because of poor access to cheap medicines and basic healthcare, the BMA says today (Wednesday, 6 July, 2005) ahead of the G8 summit.

6 Jul 2005

Keep taking Viagra, it won't make you blind!

In a review of its popular impotence treatment Viagra, Pfizer announced on Monday that it had found no evidence of increased risk of blindness among patients taking the erectile dysfunction drug.

28 Jun 2005

People with diabetes are at higher risk of contracting respiratory, urinary tract and skin infections

People with type 1 or type 2 diabetes are at higher risk of contracting respiratory, urinary tract and skin infections than people without diabetes, according to an article in the August 1 issue of Clinical Infectious Diseases, now available online.

27 Jun 2005

Yet another proven benefit of tight glucose control for those with type 1 diabetes

New study results confirm, for the first time, that intensive treatment of diabetic patients results in a significantly lower risk of heart disease. In fact, it can cut the risk of cardiovascular disease nearly in half.

16 Jun 2005

Scientists have tracked down the biological trigger that gives rise to Van Buchem disease

...a hereditary, disfiguring bone disorder that can cause blindness and deafness. The findings provide insight into long-range gene regulation and could lead to new treatments for osteoporosis and other crippling bone disorders.

16 Jun 2005

Fewer diabetics end up in hospital

According to new research from the U.S. Centers for Disease Control and Prevention (CDC), Americans with diabetes are less likely than they were a decade ago, to need hospitalization for serious complications such as kidney failure.

14 Jun 2005

Tight glucose control lowers CVD by about 50 percent in diabetes

A significantly lower risk of heart disease can now be added to the list of proven long-term benefits of tight glucose control in people with type 1 diabetes.

12 Jun 2005

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

A novel compound provides long-term lowering of blood glucose levels and improves plasma lipids (fats) that are often a problem in people with type 2 diabetes -- all in a once-daily pill, according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Diabetic retinopathy has been found in nearly 8 percent of pre-diabetic participants in the Diabetes Prevention Program (DPP), according to a report presented today at the American Diabetes Association's 65th Annual Scientific Sessions.

12 Jun 2005

Link between PKC enzyme and kidney disease in diabetes confirmed

Researchers at Joslin Diabetes Center have investigated PKC-beta - a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes - for more than two decades.

12 Jun 2005

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Scientists at Joslin Diabetes Center have investigated PKC-beta -- a critical enzyme implicated in the devastating complications of type 1 and type 2 diabetes -- for more than two decades.

10 Jun 2005

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

A Davidson woman has been successfully treated for her Type 1 diabetes through a procedure performed at Carolinas Medical Center. Paul F. Gores, M.D., has led a multi-disciplinary team through a series of three pancreatic islet cell transplants since the summer of 2003. The result is a patient who is now insulin-free.

8 Jun 2005

Leprosy microbes lead scientists to immune discovery

With the unusual opportunity that human leprosy infections provide for study of human immune responses, scientists have discovered how the body's early warning system prompts a rapid immune response by two separate armies of defensive cells.

29 May 2005

Two out of three Americans with type-2 diabetes do not have their disease under control

According to a new survey two out of three Americans with type-2 diabetes do not have their disease under control and are putting themselves at risk of early deaths from stroke, heart attack or kidney failure as well as blindness and limb loss.

18 May 2005

Patients with type 2 diabetes who participate in group education programs require less medication

Group-based education resulted in improved diabetes control as reflected by blood glucose levels and patients’ knowledge of diabetes. Evidence also suggested that participants in diabetes group education programs may reduce their blood pressure and body weight and increase self-empowerment, quality of life, self-management skills and treatment satisfaction.

18 May 2005

Type 2 diabetes may begin with Grandma's diet, study suggests

An innovative study published in the latest online edition of the Journal of Physiology provides the first evidence that the insulin resistance typical of type 2 diabetes can be "programmed" across two generations by poor nutrition during a grandmother’s pregnancy and lactation.

11 May 2005

Common antibiotic called minocycline may slow or prevent diabetic retinopathy

The team found that minocycline, often used to treat acne, limits by about 50 percent the retinal damage caused by microglia. Microglia are cells that act as the "cleanup crew" for the Central Nervous System (CNS).

11 May 2005

Blindness News and Research

Metformin should be in the first line of defense against type 2 diabetes

America's Children: Key National Indicators of Well-Being 2005

Nitric oxide good for some prem babies but not for others

G8 must focus on healthcare to save millions of lives

Keep taking Viagra, it won't make you blind!

People with diabetes are at higher risk of contracting respiratory, urinary tract and skin infections

Yet another proven benefit of tight glucose control for those with type 1 diabetes

Scientists have tracked down the biological trigger that gives rise to Van Buchem disease

Fewer diabetics end up in hospital

Tight glucose control lowers CVD by about 50 percent in diabetes

Muraglitazar lowers blood glucose and helps dyslipidemia seen in diabetes

Patients with newly diagnosed type 2 diabetes should be screened for retinopathy

Link between PKC enzyme and kidney disease in diabetes confirmed

Link between hyperglycemia (high blood glucose), overexpression of PKC-beta 2 and kidney disease

Three pancreatic islet cell transplants successfully treat type 1 diabetic woman

Leprosy microbes lead scientists to immune discovery

Two out of three Americans with type-2 diabetes do not have their disease under control

Patients with type 2 diabetes who participate in group education programs require less medication

Type 2 diabetes may begin with Grandma's diet, study suggests

Common antibiotic called minocycline may slow or prevent diabetic retinopathy

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News